PT-IgG avidity following vaccination with chemically inactivated acellular pertussis vaccines has been studied in different populations including in infants born to mothers who were vaccinated during pregnancy (40–42), but to our knowledge has never been studied for recombinant pertussis vaccines containing PTgen. The gene discussed is F2; the disease is pertussis.